| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 18 | 2020 | 144 | 4.130 |
Why?
|
| Adipose Tissue, Brown | 7 | 2021 | 11 | 2.840 |
Why?
|
| Follistatin | 6 | 2021 | 15 | 2.090 |
Why?
|
| Nitric Oxide | 13 | 2016 | 44 | 2.050 |
Why?
|
| Apoptosis | 11 | 2016 | 117 | 1.520 |
Why?
|
| Obesity | 4 | 2021 | 189 | 1.400 |
Why?
|
| Animals | 24 | 2021 | 1369 | 1.390 |
Why?
|
| Nitroso Compounds | 6 | 2016 | 7 | 1.110 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 104 | 1.060 |
Why?
|
| Mice | 14 | 2021 | 555 | 1.050 |
Why?
|
| Neoplastic Stem Cells | 5 | 2020 | 19 | 1.040 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2016 | 9 | 1.030 |
Why?
|
| Myostatin | 3 | 2021 | 22 | 0.960 |
Why?
|
| Signal Transduction | 7 | 2021 | 162 | 0.950 |
Why?
|
| Humans | 24 | 2021 | 4931 | 0.950 |
Why?
|
| Female | 21 | 2021 | 2964 | 0.940 |
Why?
|
| Down-Regulation | 4 | 2013 | 43 | 0.940 |
Why?
|
| Oxidative Stress | 4 | 2020 | 92 | 0.910 |
Why?
|
| Cell Differentiation | 5 | 2017 | 64 | 0.850 |
Why?
|
| Mitochondria | 4 | 2016 | 21 | 0.820 |
Why?
|
| Health | 1 | 2021 | 2 | 0.750 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2016 | 28 | 0.740 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 16 | 0.720 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 10 | 0.720 |
Why?
|
| Transforming Growth Factor beta | 3 | 2017 | 45 | 0.710 |
Why?
|
| Animal Feed | 1 | 2020 | 10 | 0.700 |
Why?
|
| Adipose Tissue, White | 2 | 2017 | 5 | 0.700 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 21 | 0.690 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 46 | 0.680 |
Why?
|
| Nitric Oxide Donors | 5 | 2016 | 8 | 0.650 |
Why?
|
| Nicotine | 1 | 2020 | 91 | 0.640 |
Why?
|
| Arginase | 4 | 2013 | 4 | 0.560 |
Why?
|
| Adipocytes, Brown | 1 | 2017 | 2 | 0.550 |
Why?
|
| Adipocytes, White | 1 | 2017 | 2 | 0.550 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 3 | 0.550 |
Why?
|
| Cell Proliferation | 5 | 2020 | 101 | 0.550 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2013 | 16 | 0.530 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 4 | 0.520 |
Why?
|
| Plant Extracts | 1 | 2016 | 9 | 0.520 |
Why?
|
| Biomarkers | 1 | 2015 | 160 | 0.460 |
Why?
|
| Energy Metabolism | 4 | 2021 | 19 | 0.450 |
Why?
|
| Up-Regulation | 5 | 2020 | 70 | 0.440 |
Why?
|
| Mice, Nude | 4 | 2016 | 34 | 0.440 |
Why?
|
| Proteomics | 1 | 2013 | 4 | 0.430 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 1 | 0.410 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 3 | 0.410 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 3 | 0.410 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 13 | 0.410 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 14 | 0.410 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 34 | 0.390 |
Why?
|
| Vitamin D | 1 | 2013 | 35 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2011 | 10 | 0.380 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 6 | 0.370 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 5 | 0.360 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 11 | 0.360 |
Why?
|
| Arginine | 6 | 2013 | 15 | 0.350 |
Why?
|
| Thermogenesis | 3 | 2021 | 5 | 0.350 |
Why?
|
| Uncoupling Protein 1 | 3 | 2021 | 6 | 0.330 |
Why?
|
| Fibronectins | 2 | 2021 | 5 | 0.320 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 14 | 0.300 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 1 | 0.300 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 17 | 0.290 |
Why?
|
| Male | 10 | 2021 | 2620 | 0.290 |
Why?
|
| Cells, Cultured | 6 | 2017 | 164 | 0.280 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2007 | 1 | 0.270 |
Why?
|
| Protein Kinases | 1 | 2007 | 3 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 10 | 0.270 |
Why?
|
| Mitochondrial Proteins | 3 | 2015 | 8 | 0.260 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 83 | 0.260 |
Why?
|
| Alkyl and Aryl Transferases | 2 | 2007 | 3 | 0.250 |
Why?
|
| Tumor Cells, Cultured | 7 | 2003 | 58 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 196 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2011 | 11 | 0.220 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2003 | 1 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 1 | 0.220 |
Why?
|
| Immediate-Early Proteins | 1 | 2003 | 1 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 9 | 0.220 |
Why?
|
| Hydrazines | 1 | 2003 | 2 | 0.210 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 15 | 0.210 |
Why?
|
| Blotting, Western | 4 | 2013 | 86 | 0.200 |
Why?
|
| Estradiol | 3 | 1999 | 47 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 62 | 0.190 |
Why?
|
| Arteriosclerosis | 2 | 1999 | 9 | 0.190 |
Why?
|
| Sex Characteristics | 1 | 2021 | 24 | 0.180 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2016 | 11 | 0.180 |
Why?
|
| Exercise | 1 | 2021 | 41 | 0.180 |
Why?
|
| Adipose Tissue, Beige | 1 | 2021 | 1 | 0.180 |
Why?
|
| Follistatin-Related Proteins | 1 | 2021 | 1 | 0.180 |
Why?
|
| Ligands | 1 | 2021 | 13 | 0.180 |
Why?
|
| Cyclin D1 | 1 | 2001 | 4 | 0.180 |
Why?
|
| MicroRNAs | 1 | 2021 | 35 | 0.180 |
Why?
|
| Immunoblotting | 3 | 2016 | 10 | 0.180 |
Why?
|
| Mecamylamine | 1 | 2020 | 6 | 0.180 |
Why?
|
| Imidazoles | 1 | 2020 | 10 | 0.180 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2020 | 7 | 0.180 |
Why?
|
| Inflammasomes | 1 | 2020 | 8 | 0.180 |
Why?
|
| Nitric Oxide Synthase | 5 | 2010 | 34 | 0.180 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 17 | 0.180 |
Why?
|
| Pyridines | 1 | 2020 | 21 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2007 | 21 | 0.170 |
Why?
|
| Muscle Development | 2 | 2011 | 12 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 72 | 0.170 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 12 | 0.160 |
Why?
|
| Inflammation | 1 | 2020 | 122 | 0.160 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 42 | 0.160 |
Why?
|
| Caspase 3 | 3 | 2016 | 16 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 1998 | 11 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2011 | 55 | 0.150 |
Why?
|
| Ion Channels | 2 | 2015 | 8 | 0.150 |
Why?
|
| Cell Cycle | 4 | 2008 | 13 | 0.150 |
Why?
|
| Multigene Family | 1 | 2017 | 5 | 0.140 |
Why?
|
| Models, Animal | 1 | 2017 | 17 | 0.140 |
Why?
|
| Cyclic GMP | 2 | 2008 | 14 | 0.140 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2017 | 7 | 0.140 |
Why?
|
| Isoenzymes | 2 | 2016 | 10 | 0.140 |
Why?
|
| 3T3-L1 Cells | 1 | 2017 | 4 | 0.140 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1997 | 1 | 0.140 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1997 | 1 | 0.140 |
Why?
|
| Cancer Vaccines | 1 | 1997 | 4 | 0.140 |
Why?
|
| Immunotherapy | 1 | 1997 | 13 | 0.130 |
Why?
|
| Testosterone | 2 | 2011 | 43 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 23 | 0.130 |
Why?
|
| Vernonia | 1 | 2016 | 2 | 0.130 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 3 | 0.130 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 5 | 0.130 |
Why?
|
| Retinal Dehydrogenase | 1 | 2016 | 3 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 33 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2013 | 32 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2015 | 8 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2015 | 11 | 0.120 |
Why?
|
| Receptors, Androgen | 3 | 2011 | 19 | 0.110 |
Why?
|
| Adipocytes | 1 | 2014 | 22 | 0.110 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2013 | 1 | 0.110 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 4 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 5 | 0.110 |
Why?
|
| RNA Interference | 1 | 2013 | 10 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2013 | 14 | 0.110 |
Why?
|
| Caspases | 3 | 2002 | 15 | 0.110 |
Why?
|
| Cytochrome c Group | 2 | 2003 | 3 | 0.100 |
Why?
|
| Rats, Inbred ACI | 1 | 2013 | 1 | 0.100 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2013 | 1 | 0.100 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 2 | 0.100 |
Why?
|
| Cell Separation | 1 | 2013 | 3 | 0.100 |
Why?
|
| Retinoid X Receptors | 1 | 2013 | 4 | 0.100 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 5 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 9 | 0.100 |
Why?
|
| African Americans | 1 | 2016 | 256 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 11 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11 | 0.100 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2011 | 3 | 0.090 |
Why?
|
| Immunoprecipitation | 2 | 2008 | 10 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 21 | 0.090 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2011 | 1 | 0.090 |
Why?
|
| Macromolecular Substances | 1 | 2011 | 3 | 0.090 |
Why?
|
| Protein Stability | 1 | 2011 | 2 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2011 | 3 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 16 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2011 | 36 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2008 | 22 | 0.090 |
Why?
|
| Enzyme Inhibitors | 5 | 2001 | 35 | 0.080 |
Why?
|
| Disease Progression | 1 | 2010 | 137 | 0.080 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2008 | 1 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 2 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2008 | 10 | 0.080 |
Why?
|
| beta Catenin | 1 | 2008 | 8 | 0.080 |
Why?
|
| Middle Aged | 1 | 2013 | 1544 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 19 | 0.080 |
Why?
|
| Heme | 1 | 2008 | 1 | 0.070 |
Why?
|
| eIF-2 Kinase | 1 | 2008 | 1 | 0.070 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 2 | 0.070 |
Why?
|
| Genes, ras | 1 | 2008 | 2 | 0.070 |
Why?
|
| Oxidants | 1 | 2008 | 2 | 0.070 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 2 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 7 | 0.070 |
Why?
|
| Breast | 1 | 2008 | 5 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 16 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 126 | 0.070 |
Why?
|
| Ovariectomy | 2 | 1998 | 18 | 0.070 |
Why?
|
| Endothelium, Vascular | 2 | 1999 | 29 | 0.070 |
Why?
|
| Gene Expression | 3 | 2011 | 55 | 0.070 |
Why?
|
| raf Kinases | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 2 | 0.070 |
Why?
|
| Cell Division | 3 | 2001 | 35 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 11 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 7 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2007 | 13 | 0.070 |
Why?
|
| Intracellular Membranes | 2 | 2003 | 6 | 0.070 |
Why?
|
| Membrane Potentials | 2 | 2003 | 12 | 0.070 |
Why?
|
| Enzyme Induction | 2 | 2003 | 9 | 0.060 |
Why?
|
| Orchiectomy | 2 | 2008 | 7 | 0.060 |
Why?
|
| Protein Phosphatase 1 | 1 | 2003 | 1 | 0.050 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2003 | 2 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 5 | 0.050 |
Why?
|
| Cytosol | 1 | 2003 | 12 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 2014 | 28 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2014 | 112 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2002 | 13 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 64 | 0.050 |
Why?
|
| Rabbits | 2 | 1999 | 33 | 0.050 |
Why?
|
| Polyamines | 1 | 2001 | 5 | 0.050 |
Why?
|
| Farnesyltranstransferase | 1 | 2001 | 2 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2001 | 22 | 0.050 |
Why?
|
| G1 Phase | 1 | 2001 | 1 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 3 | 0.050 |
Why?
|
| Dihydrotestosterone | 1 | 2000 | 4 | 0.040 |
Why?
|
| Citrulline | 2 | 1997 | 9 | 0.040 |
Why?
|
| Brain | 1 | 2000 | 78 | 0.040 |
Why?
|
| Leukocytes | 1 | 1999 | 7 | 0.040 |
Why?
|
| Cholesterol, Dietary | 1 | 1998 | 2 | 0.040 |
Why?
|
| Ovary | 1 | 1998 | 12 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 1998 | 127 | 0.040 |
Why?
|
| Endometrium | 1 | 1997 | 22 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2000 | 176 | 0.030 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1997 | 1 | 0.030 |
Why?
|
| Hemocyanins | 1 | 1997 | 1 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 1997 | 3 | 0.030 |
Why?
|
| Rats | 4 | 2000 | 373 | 0.030 |
Why?
|
| Kidney | 1 | 1997 | 165 | 0.030 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2014 | 2 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2014 | 2 | 0.030 |
Why?
|
| Proton Ionophores | 1 | 2014 | 2 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 9 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 22 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2014 | 20 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 2 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 5 | 0.030 |
Why?
|
| Genotype | 1 | 2013 | 18 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 26 | 0.030 |
Why?
|
| Body Composition | 1 | 2013 | 45 | 0.030 |
Why?
|
| PAX7 Transcription Factor | 1 | 2011 | 2 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 6 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 6 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2011 | 9 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 10 | 0.020 |
Why?
|
| Ornithine | 2 | 2001 | 2 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2001 | 12 | 0.020 |
Why?
|
| Sex Factors | 2 | 2000 | 120 | 0.020 |
Why?
|
| Karyopherins | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2008 | 1 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 4 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 7 | 0.020 |
Why?
|
| Transcription Factor 4 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 2 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 2 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 3 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 15 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 16 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 24 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 82 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 32 | 0.020 |
Why?
|
| Mutation | 1 | 2008 | 51 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2002 | 2 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 3 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2002 | 3 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 43 | 0.010 |
Why?
|
| Adenosylmethionine Decarboxylase | 1 | 2001 | 1 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2001 | 4 | 0.010 |
Why?
|
| Ornithine Decarboxylase | 1 | 2001 | 3 | 0.010 |
Why?
|
| Cyclins | 1 | 2001 | 7 | 0.010 |
Why?
|
| Spermine | 1 | 2000 | 1 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 4 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2000 | 41 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2000 | 19 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Diet, Atherogenic | 1 | 1999 | 3 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1999 | 17 | 0.010 |
Why?
|
| Cell Movement | 1 | 1999 | 24 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1999 | 11 | 0.010 |
Why?
|
| Aorta | 1 | 1999 | 16 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1997 | 1 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1997 | 8 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1997 | 7 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1997 | 4 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1997 | 15 | 0.010 |
Why?
|
| Calmodulin | 1 | 1997 | 1 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1997 | 1 | 0.010 |
Why?
|
| Isothiuronium | 1 | 1997 | 1 | 0.010 |
Why?
|
| Sepharose | 1 | 1997 | 1 | 0.010 |
Why?
|
| Nitrates | 1 | 1997 | 4 | 0.010 |
Why?
|
| Nitrites | 1 | 1997 | 6 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1997 | 98 | 0.010 |
Why?
|
| Urea | 1 | 1996 | 15 | 0.010 |
Why?
|
| Calcium | 1 | 1997 | 63 | 0.010 |
Why?
|
| Pregnancy | 1 | 1997 | 417 | 0.010 |
Why?
|